United Therapeutics Corporation
UTHR
$477.91
-$2.04-0.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.77B | 3.05B | 3.32B | 3.27B | 3.33B |
| Total Receivables | 297.70M | 379.30M | 322.00M | 279.30M | 341.80M |
| Inventory | 176.50M | 169.20M | 165.40M | 157.90M | 146.70M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 252.20M | 229.70M | 131.10M | 169.70M | 185.40M |
| Total Current Assets | 3.49B | 3.83B | 3.94B | 3.87B | 4.00B |
|
|
|||||
| Total Current Assets | 3.49B | 3.83B | 3.94B | 3.87B | 4.00B |
| Net Property, Plant & Equipment | 1.56B | 1.36B | 1.30B | 1.22B | 1.16B |
| Long-term Investments | -- | -- | -- | 32.30M | -- |
| Goodwill | -- | -- | -- | 32.30M | -- |
| Total Other Intangibles | 116.70M | 111.50M | 111.70M | 79.60M | 112.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 528.50M | 630.50M | 620.00M | 621.50M | 545.50M |
| Total Assets | 7.35B | 7.91B | 7.74B | 7.36B | 7.12B |
|
|
|||||
| Total Accounts Payable | 468.00M | 432.00M | 367.00M | 6.00M | 363.90M |
| Total Accrued Expenses | -- | -- | -- | 380.30M | 29.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 200.00M | 306.10M | 400.00M |
| Total Finance Division Other Current Liabilities | 78.30M | 95.10M | 154.50M | 45.70M | 80.10M |
| Total Other Current Liabilities | 78.30M | 95.10M | 154.50M | 45.70M | 80.10M |
| Total Current Liabilities | 546.30M | 527.10M | 721.50M | 738.10M | 873.40M |
|
|
|||||
| Total Current Liabilities | 546.30M | 527.10M | 721.50M | 738.10M | 873.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 32.50M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 214.60M | 207.30M | 215.20M | 149.40M | 148.80M |
| Total Liabilities | 760.90M | 734.40M | 936.70M | 920.00M | 1.02B |
|
|
|||||
| Common Stock & APIC | 2.66B | 2.79B | 2.74B | 2.70B | 2.65B |
| Retained Earnings | 8.19B | 7.85B | 7.54B | 7.22B | 6.92B |
| Treasury Stock & Other | -4.26B | -3.47B | -3.48B | -3.48B | -3.47B |
| Total Common Equity | 6.59B | 7.17B | 6.81B | 6.44B | 6.10B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.59B | 7.17B | 6.81B | 6.44B | 6.10B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.59B | 7.17B | 6.81B | 6.44B | 6.10B |
|
|
|||||